1391 related articles for article (PubMed ID: 18186694)
1. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
2. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer.
Bahn DK; Lee F; Badalament R; Kumar A; Greski J; Chernick M
Urology; 2002 Aug; 60(2 Suppl 1):3-11. PubMed ID: 12206842
[TBL] [Abstract][Full Text] [Related]
3. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
[TBL] [Abstract][Full Text] [Related]
4. Cryosurgical ablation of the prostate: high risk patient outcomes.
Prepelica KL; Okeke Z; Murphy A; Katz AE
Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
[TBL] [Abstract][Full Text] [Related]
5. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
[TBL] [Abstract][Full Text] [Related]
6. Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution.
Ball AJ; Gambill B; Fabrizio MD; Davis JW; Given RW; Lynch DF; Shaves M; Schellhammer PF
J Endourol; 2006 Oct; 20(10):723-31. PubMed ID: 17094746
[TBL] [Abstract][Full Text] [Related]
7. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
8. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience.
Han KR; Cohen JK; Miller RJ; Pantuck AJ; Freitas DG; Cuevas CA; Kim HL; Lugg J; Childs SJ; Shuman B; Jayson MA; Shore ND; Moore Y; Zisman A; Lee JY; Ugarte R; Mynderse LA; Wilson TM; Sweat SD; Zincke H; Belldegrun AS
J Urol; 2003 Oct; 170(4 Pt 1):1126-30. PubMed ID: 14501706
[TBL] [Abstract][Full Text] [Related]
9. Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry.
Dhar N; Ward JF; Cher ML; Jones JS
BJU Int; 2011 Aug; 108(4):508-12. PubMed ID: 21722288
[TBL] [Abstract][Full Text] [Related]
10. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
[TBL] [Abstract][Full Text] [Related]
11. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332
[TBL] [Abstract][Full Text] [Related]
12. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
Kang SH; Kim JW; Bae JH; Park HS; Moon DG; Yoon DK; Cheon J; Kim JJ
Asian J Androl; 2006 Sep; 8(5):629-36. PubMed ID: 16847531
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
Liu YY; Chiang PH
Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
[TBL] [Abstract][Full Text] [Related]
14. Initial brazilian experience in the treatment of localized prostate cancer using a new generation cryotechnology: feasibility study.
Kim FJ; Cerqueira MA; Almeida JC; Pompeo A; Sehrt D; Calheiros JM; Martins FA; Molina WR
Int Braz J Urol; 2012; 38(5):620-6. PubMed ID: 23131504
[TBL] [Abstract][Full Text] [Related]
15. Definition of biochemical success following primary whole gland prostate cryoablation.
Levy DA; Ross AE; ElShafei A; Krishnan N; Hatem A; Jones JS
J Urol; 2014 Nov; 192(5):1380-4. PubMed ID: 24813344
[TBL] [Abstract][Full Text] [Related]
16. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
Gondi V; Deutsch I; Mansukhani M; O'Toole KM; Shah JN; Schiff PB; Katz AE; Benson MC; Goluboff ET; Ennis RD
Urology; 2007 Mar; 69(3):541-6. PubMed ID: 17382161
[TBL] [Abstract][Full Text] [Related]
17. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
[TBL] [Abstract][Full Text] [Related]
19. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
[TBL] [Abstract][Full Text] [Related]
20. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
Lambert EH; Bolte K; Masson P; Katz AE
Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
